Shanna Helms LPCA

Recommended Articles

• What Is Astigmatism?

  Normally, the eye, cornea, and lens can easily focus light rays on the retina. The disease known asastigmatism is an imperfection in the curvature of the cornea, and it can produce a clear, round dome covering the iris and pupil.The cornea and lens remain smooth and are always curved equally in all...

• Why Alzheimer's Caregivers Are At Risk for Depression

  It’s a very common story. Someone receives a diagnosis of a disease or disorder that will at some point require constant care, then a loved one, a parent, spouse, child or sibling, jumps into caregiver mode. Over time, as the needs of the patient grows, the pressure of being a caregiver is 24/7...

• Three Women in One Family Battle Breast Cancer Together

  Genetics are a risk factor that no one can avoid when it comes to having a higher risk of disease. Genes passed down from parents inform the way that every cell grows and behaves.Breast cancer is one of the diseases that has a hereditary risk factor. It is estimated that between 5% and 10% of all...

• Compound In Cocoa May Delay Onset of Type-II Diabetes

  The Benefits of Compounds in ChocolateResearch Into Cocoa and Type-II DiabetesAccording to researchers by those at Brigham Young University, there could very well be a tie-in between certain compounds found in cocoa and producing more insulin. In addition to these studies suggesting the benefits of...

• Why an Alzheimer's Patient May Be Violent

  Violent and aggressive behavior is an issue that many with Alzheimer's face, and it also affects their friends and family. It doesn't happen as frequent as other symptoms, but when it does, it usually happens out of pressure or stress that the patient may be feeling. There could be quite a few...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...